# Paclitaxel Eluting Covered Metallic Stent for Unresectable Malignant Bile Duct Obstruction

> **NCT00453076** · PHASE3 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 52 (actual)

## Conditions studied

- Bile Duct Obstruction

## Interventions

- **DEVICE:** Paclitaxel eluting covered metal stent and control covered metal stent

## Key facts

- **NCT ID:** NCT00453076
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2008-06
- **Final completion:** 2009-06
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2010-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00453076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00453076, "Paclitaxel Eluting Covered Metallic Stent for Unresectable Malignant Bile Duct Obstruction". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00453076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*